TempraMed Technologies Ltd. (VIVI)
CSE
0.5100
-0.01 (-1.92%)
Real-time Data
01:30 PM
Day's Range
0.51000.5200
52 wk Range
0.27001.40
Financial Statements - VIVI - TempraMed Technologies Ltd.
Revenue
1.84M▼ 18.6%
Net Income
-18.19M▼ 442.4%Net Margin -987.0%
EBITDA
-4.44M▼ 97.9%
Free Cash Flow
-3.81M▼ 305.5%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 1.84M | 2.26M |
| Cost of Goods | 947K | 845K |
| Gross Profit | 896K | 1.41M |
 Operating Expense | - | - |
| Operating Income | -4.48M | -2.26M |
| Non-Operating Interest | - | - |
| Other Income Expense | -13.20M | -761K |
| Pre Tax Income | -18.19M | -3.35M |
| Income Tax | - | - |
| Net Income | -18.19M | -3.35M |
| EPS Basic | -0.43 | -0.045673 |
| EPS Diluted | -0.43 | -0.045673 |
| Basic Shares Outstanding | 42.53M | - |
| Diluted Shares Outstanding | 42.53M | - |
| Ebit | -17.69M | -3.04M |
| Ebitda | -4.44M | -2.24M |
| Net Income Continuous Operations | -18.19M | -3.35M |
| Minority Interests | - | - |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
